Last Updated: 31-07-2025 | Format: PDF | Report ID:20503 | Author: Lena
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $1,580 Million |
| What is the projected market size by 2035? | $2,650 Million |
| What is the market CAGR from 2025 to 2035? | 5.3% |
| Which region dominates the market? | US (72%) |
| Which product/service type dominates the market? | Allergen Assay Kits (47%) |
| Which application leads the market? | Inhaled Allergens (42%) |
| Who are the major buyers? | Hospital-based Laboratories (49%), Diagnostic Laboratories (33%) |
| What are the key market growth drivers? | Rising Prevalence of Allergic Diseases – The number of individuals diagnosed with allergies continues to grow across North America due to environmental changes and evolving lifestyles; Advancements in Diagnostic Technologies – Breakthroughs such as multiplex assays and LC-MS/MS enhance early detection and management of multiple allergens |
| What are the major market challenges? | Stringent Regulatory Requirements – Complex and evolving regulations pose challenges for market entry and compliance; Shortage of Skilled Laboratory Professionals – The increasing complexity of allergy diagnostics requires skilled technicians |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| What is the forecast period? |
| 2026–2035 |
| Who are the key market players? | Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, bioMérieux, Omega Diagnostics Group, Eurofins Scientific, Stallergenes Greer, HYCOR Biomedical, Lincoln Diagnostics, Romer Labs, R-Biopharm, PerkinElmer, AllerGenis, Mindray Medical International |
Global Digital Biomarkers Market: by Type (Wearable Devices, Mobile Health Apps, Biosensors, Clinical Trials Platforms, Digital Diagnostics, Passive Monitoring Systems), Application (Cardiovascular Disease, Neurodegenerative Disorders, Diabetes, Respiratory Disease, Oncology, Others), Distribution Channels (Hospitals, Clinics, Research Centers, Homecare, Pharmacies, Online), Technology (Artificial Intelligence, Internet of Things, Machine Learning, Cloud Computing, Blockchain, Data Analytics), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Wearables in Pharma & Biotech Market: by Type (Smartwatches, Fitness Trackers, Patches, Smart Clothing, Biosensors, Implantables), Application (Remote Patient Monitoring, Clinical Trials, Disease Management, Diagnostics, Fitness & Wellness, Drug Delivery), Distribution Channels (Online, Offline/Pharmacy, Direct, Distributors, Hospitals, Clinics), Technology (Bluetooth, Wi-Fi, NFC, Cellular, RFID, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
US Pre-Market Biomedical Software Market: by Type (Clinical Decision Support Software, Medical Imaging Software, Electronic Health Records Software, Telemedicine Software, Patient Monitoring Software, Laboratory Information Management Systems), Application (Hospitals, Clinics, Research Institutes, Diagnostics Centers, Ambulatory Surgical Centers, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Retail, Partnerships, Others), Technology (Cloud-based, On-premise, AI & Machine Learning, Blockchain, Big Data Analytics, IoT-enabled), Organization Size (Small, Medium, Large) and By US Historical & Forecast Period (2020-2035) Comprehensive Study 2025
US Early Stage Cancer Market Market: by Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Other Cancers), Application (Diagnosis, Screening, Monitoring, Prognosis, Treatment Planning, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Research Institutes, Retail Pharmacies, Online Providers, Others), Technology (Imaging, Molecular Diagnostics, Genomics, Biomarker Testing, Others), Organization Size (Small, Medium, Large) and By US Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Europe Early Stage Cancer Market: by Type (Biomarker-based Screening, Imaging-based Screening, Liquid Biopsy, Molecular Diagnostics, Immunoassay, Others), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Others), Distribution Channels (Hospitals, Diagnostic Centers, Cancer Research Institutes, Specialty Clinics, Ambulatory Surgical Centers, Others), Technology (PCR, Next-Generation Sequencing, Immunohistochemistry, In Situ Hybridization, Flow Cytometry, Others), Organization Size (Small, Medium, Large) and By Europe Historical & Forecast Period (2020-2035) Comprehensive Study 2025